⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
JSPR News
Jasper Therapeutics, Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Jasper Therapeutics, Inc. (JSPR) And Encourages Investors to Reach Out
accessnewswire.com
JSPR
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Jasper Therapeutics, Inc. (JSPR) And Encourages Stockholders to Reach Out
accessnewswire.com
JSPR
Bronstein, Gewirtz & Grossman, LLC Is Investigating Jasper Therapeutics, Inc. (JSPR) And Encourages Stockholders to Connect
accessnewswire.com
JSPR
Lifshitz Law PLLC Announces Investigations of Quanex Building Products Corporation (NYSE: NX), Jasper Therapeutics, Inc. (NASDAQ: JSPR), RCI Hospitality Holdings, Inc. (NASDAQ: RICK), and Molina Healthcare, Inc. (NYSE: MOH)
accessnewswire.com
NX
JSPR
RICK
MOH
Jasper Therapeutics, Inc. (JSPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
JSPR
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Jasper Therapeutics, Inc. (JSPR) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
JSPR
Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation
globenewswire.com
JSPR
Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation
globenewswire.com
JSPR
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
newsfilecorp.com
JSPR
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
newsfilecorp.com
JSPR